Similar articles

• Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.

  Bruckert E, Giral P, Tellier P. Bruckert E, et al. Circulation. 2003 Jul 1;107(25):3124-8. doi: 10.1161/01.CIR.0000072345.98581.24. Circulation. 2003. PMID: 12835406 Review. No abstract available.
• Therapy and clinical trials: ezetimibe.

  Jialal I, Kappagoda T. Jialal I, et al. Curr Opin Lipidol. 2003 Dec;14(6):643-6. doi: 10.1097/00041433-200312000-00015. Curr Opin Lipidol. 2003. PMID: 14624143 No abstract available.
• [Cholesterol absorption as a target for the treatment of hypercholesterolemia].

  Bitzur R, Cohen H, Harats D. Bitzur R, et al. Harefuah. 2006 Nov;145(11):831-5, 861, 860. Harefuah. 2006. PMID: 17183957 Review. Hebrew.
• Ezetimibe (Schering-Plough).

  Meng CQ. Meng CQ. Curr Opin Investig Drugs. 2001 Mar;2(3):389-92. Curr Opin Investig Drugs. 2001. PMID: 11575710
• Zetia (ezetimibe).

  Kloner RA. Kloner RA. Congest Heart Fail. 2003 Mar-Apr;9(2):109-10. doi: 10.1111/j.1527-5299.2003.02434.x. Congest Heart Fail. 2003. PMID: 12671344 No abstract available.